AU9695698A - Method for purifying retroviral particles and soluble viral antigens - Google Patents

Method for purifying retroviral particles and soluble viral antigens

Info

Publication number
AU9695698A
AU9695698A AU96956/98A AU9695698A AU9695698A AU 9695698 A AU9695698 A AU 9695698A AU 96956/98 A AU96956/98 A AU 96956/98A AU 9695698 A AU9695698 A AU 9695698A AU 9695698 A AU9695698 A AU 9695698A
Authority
AU
Australia
Prior art keywords
viral antigens
retroviral particles
soluble viral
purifying
purifying retroviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU96956/98A
Inventor
Yichen Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSTITUTE FOR VACCINE DEVELOPMENT
Celldex Therapeutics Inc
Original Assignee
INST VACCINE DEV
Avant Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST VACCINE DEV, Avant Immunotherapeutics Inc filed Critical INST VACCINE DEV
Publication of AU9695698A publication Critical patent/AU9695698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU96956/98A 1997-10-14 1998-10-14 Method for purifying retroviral particles and soluble viral antigens Abandoned AU9695698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94934997A 1997-10-14 1997-10-14
US08949349 1997-10-14
PCT/US1998/021737 WO1999019345A1 (en) 1997-10-14 1998-10-14 Method for purifying retroviral particles and soluble viral antigens

Publications (1)

Publication Number Publication Date
AU9695698A true AU9695698A (en) 1999-05-03

Family

ID=25488959

Family Applications (1)

Application Number Title Priority Date Filing Date
AU96956/98A Abandoned AU9695698A (en) 1997-10-14 1998-10-14 Method for purifying retroviral particles and soluble viral antigens

Country Status (2)

Country Link
AU (1) AU9695698A (en)
WO (1) WO1999019345A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2343023T3 (en) * 2000-03-27 2010-07-21 Genetics Institute, Llc PROCEDURES TO PURIFY HIGHLY ANIONIC PROTEINS.
CN101018804A (en) * 2004-07-27 2007-08-15 基诺美生物工程（制药）公司 Method of purifying virus envelope
WO2007054297A2 (en) * 2005-11-11 2007-05-18 Csl Behring Gmbh Use of hydrophobic interaction chromatography for the attenuation of viruses
CN102018955A (en) * 2010-12-27 2011-04-20 吉林亚泰生物药业股份有限公司 Purification method for producing viral vaccine in large scale

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243103B1 (en) * 1986-04-25 1992-12-30 Merck & Co. Inc. Purification of pre-s hbsag by polymerized serum albumin affinity binding
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation

Also Published As

Publication number Publication date
WO1999019345A1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
AU4803196A (en) Recombinant DNA virus and method for preparation thereof
IL141044A0 (en) Innunological herpes simplex virus antigens and methods for use thereof
AU1566595A (en) Method and reagent for inhibiting hepatitis c virus replication
AU4366596A (en) Fugitive emissions detection system and components thereof
AU9112298A (en) System and process for inter-domain interaction across an inter-domain connectivity plane
AU1162999A (en) Separation process and apparatus
AU8644898A (en) System and method for handling permits
AU8146798A (en) System and process for allowing wireless messaging
AU6789298A (en) Porous ceramic articles and method for the manufacture thereof
AU7978198A (en) Method for purifying viral nucleic acids
AU7075298A (en) Conveying means and method
AU7696198A (en) Apparatus and method for high efficiency hemofiltration
AU1711600A (en) Filter for removing fine particles
AU5209498A (en) Process and apparatus for gas separation
AU4353897A (en) Viral defective interfering particles and uses thereof
AU2373597A (en) Particulate materials
AU7165498A (en) Methods for treating viral infections
AU2587795A (en) Epstein-barr virus transcription factor binding assay
AU4145897A (en) Method and apparatus for purifying water-insoluble compounds
AU7831498A (en) Low density silica particles and method for their preparation
AU7508696A (en) Process for the preparation of porous polyyolefin particles
AU2761897A (en) Spongy silica particles and method for preparing the same
AU1495799A (en) Method and apparatus for separating particles
AU698277B2 (en) Particulate materials
AU9695698A (en) Method for purifying retroviral particles and soluble viral antigens

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase